| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004010974A3 Gelatin capsule exhibiting reduced cross-linking |
| 08/05/2004 | WO2004010973A3 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003070204A3 Lipase inhibiting composition |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | US20040153126 Method and apparatus for treating uterine myoma |
| 08/05/2004 | US20040152906 Sulfonamides |
| 08/05/2004 | US20040152893 Sulfonamides |
| 08/05/2004 | US20040152891 Sulfonamides |
| 08/05/2004 | US20040152868 Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease |
| 08/05/2004 | US20040152785 Antiarthritic agents; bone disorders; oral diseases; nephritis; atherosclerosis; respiratory system disorders; cirrhosis; vision defects; anticancer agents; autoimmune diseases |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152754 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152744 Phenylacetic acid derivative; hypoglycemic agents; antilipemic agents; antichoilesterol agents; cardiovascular disorders |
| 08/05/2004 | US20040152738 Wound healing agents; antiarthritic agents; osteoporosis; congestive heart failure; antiulcer agents; Alzheimer's disease; anticholesterol agents; antiarthritic agents |
| 08/05/2004 | US20040152730 Novel compounds |
| 08/05/2004 | US20040152726 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 08/05/2004 | US20040152725 Anticancer agents using a compound containing urea group |
| 08/05/2004 | US20040152705 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives |
| 08/05/2004 | US20040152636 For therapy of diseases or disorders characterized by undesirable excessive vascularization such as tumors, rheumatoid arthritis, psoriasis, atherosclerosis, diabetic and other retinopathies, retrolental fibroplasia, macular degeneration |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040151754 Steroid suspensions for intraocular use |
| 08/05/2004 | CA2513004A1 Aptamer therapeutics useful in ocular pharmacotherapy |
| 08/05/2004 | CA2512043A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 08/04/2004 | EP1443110A2 Human VEGF-specific antisense oligonucleotides |
| 08/04/2004 | EP1442121A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442042A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 08/04/2004 | EP1442041A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease |
| 08/04/2004 | EP1442037A1 Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
| 08/04/2004 | EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors |
| 08/04/2004 | EP1442033A1 Omega-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 08/04/2004 | EP1442023A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/04/2004 | EP1442008A1 Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 08/04/2004 | EP1441751A1 TARGETING THE REVERSE MODE OF THE Na+ /Ca2+ EXCHANGER FOR THE TREATMENT OF OPTIC NEUROPATHY ASSOCIATED WITH GLAUCOMA AND ISCHEMIC OPTIC NEUROPATHY |
| 08/04/2004 | EP1441743A2 Methods for treating ocular neovascular diseases |
| 08/04/2004 | EP1441730A1 Hydrazono-malonitriles |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441701A1 Montelukast granule formulation |
| 08/04/2004 | EP1441696A1 Method and composition for dry eye treatment |
| 08/04/2004 | EP1289945B1 Aniline disulfide derivatives for treating allergic diseases |
| 08/04/2004 | EP1278750B1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 08/04/2004 | EP1228032B1 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP1140021B1 Improved formulation for topical non-invasive application in vivo |
| 08/04/2004 | EP1124829B1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 08/04/2004 | EP1064256B1 Bicyclo [2.2.1] heptanes and related compounds |
| 08/04/2004 | CN1518552A Pyrrolopyrimidines as protein kinase inhitibors |
| 08/04/2004 | CN1518551A Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 08/04/2004 | CN1518549A Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 08/04/2004 | CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3 |
| 08/04/2004 | CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 08/04/2004 | CN1518463A Safety shield system for prefilled syringes |
| 08/04/2004 | CN1518448A Antihistamines for treatment of nasal congestion and nasal obstruction |
| 08/04/2004 | CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 08/04/2004 | CN1517089A Indometacin eyedrops |
| 08/04/2004 | CN1517087A Txoxerutin for preparing ege drops to treat different kinds of egeground affection or vision fatigue |
| 08/04/2004 | CN1160359C Dithiepino [6,5-b] pyridines, and related compsns. and methods for preparing and use |
| 08/04/2004 | CN1160356C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160338C N-[4-(3-chloro-4-fluoro-phenylamino)-7-(-3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 08/04/2004 | CN1160312C Substituted alkyl tetramine dervative |
| 08/04/2004 | CN1160091C Medcine for treating conjunctivitis and keratitis |
| 08/03/2004 | US6770743 Genetic engineered drug |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770643 Inhibit protein kinases |
| 08/03/2004 | US6770637 Substituted 4-phenyl-pyridine compounds with activity as antagonists of neurokinin 1 receptors |
| 08/03/2004 | CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 08/03/2004 | CA2127542C Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 08/03/2004 | CA2058768C Treatment and control of ocular development |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062670A2 Radiopaque animal chew |
| 07/29/2004 | WO2004062669A1 Use of a macrolide compound for treating dry eye |
| 07/29/2004 | WO2004062660A1 Contact lens and eye drop rewetter compositions and their uses |
| 07/29/2004 | WO2004050086A8 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 07/29/2004 | WO2004043480A3 Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004017971A8 Use of a papaverine-like vasodilator and pharmaceutical composition |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003097798A3 Carotene synthase gene and uses therefor |
| 07/29/2004 | WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 07/29/2004 | WO2003086317A3 Protein a compositions and methods of use |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147603 Malic acid addition salts of terbinafine |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147542 Chemical compounds |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |